Mapp Biopharmaceutical, Inc. is a biotechnology company located in San Diego, California, United States. Mapp's mission is to develop monoclonal antibody drugs for neglected infectious diseases. EXPANDED ACCESS POLICY Mapp Biopharmaceutical, Inc. (Mapp) investigational products may be made available for use in eligible patients with documented disease or a well-documented high-risk exposure to a pathogen for which Mapp has available material. Mapp investigational products available under expanded access are investigational medicine, and have not been licensed by the U.S. Food and Drug Administration (FDA) or other health authorities. Patients should work closely with their physician to understand the potential benefits and risks of an investigational product prior to use. Physicians seeking expanded access to Mapp investigational products for a patient should submit their request to expandedaccess@mappbio.com.